| Home | E-Submission | Sitemap | Contact Us |  
J Neurocrit Care 2008;1(1): 73-78.
악성 중대뇌동맥 뇌경색: 생존을 위해 어떻게 해야하나
손성일, 손성일
계명대학교 의과대학 동산의료원 신경과학교실
Malignant Middle Cerebral Artery Infarction: Dos and Don’t for Survival
Sung-Il Sohn, MD, PhD Sung-Il Sohn, MD, PhD
Department of Neurology, Dongsan Medical Center, Keimyung University School of Medicine, Daegu, Korea
Malignant infarction of the middle cerebral artery (MCA) is associated with an 80% mortality rate. No medical treatment has been proven effective. But decompressive hemicraniectomy and induced hypothermia have been proposed to relieve the mass effect and tissue shifts. Further analyses of current trial data suggest that in particular patient age and timing of hemicraniectomy determine outcome. Identification of patients at risk to develop malignant cerebral edema after massive infarcts is therefore of importance. Different predictors of fatal brain edema formation have been identified, such as large volume or area on early CT or MRI and midline shifting on repeated CT or transcranial color-coded duplex sonography. Nevertheless, there is no proven therapy for all patients with malignant MCA infarction. In order to guide the management of individual patients, carefully adjusted medical care, ongoing futility analysis, and simultaneous health professionals meetings should be conducted to reach a joint decision addressing any ethical concerns.
Key Words: Malignant MCA infarction·Hemicraniectomy
Editorial Office
Department of Neurology and Critical Care, Seoul National University Hospital,
101, Daehak-ro, Jongno-gu, Seoul, 03080 Korea
TEL: +82-2-2072-0743 (10:00 AM ~ 4:00 PM) / +82-2-2072-1810   FAX: +82-2-3672-7553    E-mail: office@e-jnc.org

Copyright© Korean Neurocritical Care Society.                Developed in M2PI